Skip to content

Phreesia医疗支付

US · PHR #3570 按市值排名 上市于 2019
10.94 -0.10 -0.91%
实时 - 追踪5344个代码 - 心跳于521秒前 · 2026-10-16 19:30

最新新闻

  • William Blair Maintains Phreesia(PHR.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/10/3
  • 评级变动
    D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Cuts Target Price to $13
    \u5e02\u573a\u8d44\u8baf · 2026/9/4
  • 评级变动
    A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $14 to $19
    \u5e02\u573a\u8d44\u8baf · 2026/9/3
  • Raymond James Downgrades Phreesia(PHR.US) to Hold Rating, Cuts Target Price to $12
    \u5e02\u573a\u8d44\u8baf · 2026/9/8
  • 评级变动
    BMO Capital Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14
    \u5e02\u573a\u8d44\u8baf · 2026/6/22
  • 评级变动
    Barclays Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/6/15
  • 评级变动
    Needham Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14
    \u5e02\u573a\u8d44\u8baf · 2026/8/31
  • RBC Capital Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $19
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • 公司公告
    Tecmira Holdings: Wellmira and Arteryex have demonstrated the effectiveness of multidisciplinary collaboration leveraging PHR.
    JPX · 2026/6/1
  • Analysts Are Bullish on Top Healthcare Stocks: Alto Neuroscience, Inc. (ANRO), Phreesia (PHR)
    TipRanks · 2026/10/3
  • 评级变动
    A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $12 to $16
    \u5e02\u573a\u8d44\u8baf · 2026/5/29
  • 公司公告
    JMDC: Mitsubishi UFJ Bank, Omron, and JMDC are collaborating to promote regular blood pressure monitoring among all approximately 30,000 employees—leveraging PHR (Personal Health Record) technology to advance both self-care and advanced health management.
    JPX · 2026/6/30
  • 评级变动
    J.P. Morgan Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $14
    \u5e02\u573a\u8d44\u8baf · 2026/6/25
  • 评级变动
    CCORF Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $16
    \u5e02\u573a\u8d44\u8baf · 2026/8/12
  • 公司公告
    Alfresa Holdings: We are conducting a demonstration project to improve dietary habits through product recommendations and health support leveraging PHR data, with the aim of extending the healthy life expectancy of Tsukuba City residents and preventing lifestyle-related diseases.
    JPX · 2026/8/21
  • 公司公告
    JMDC: JMDC has confirmed that the practice of recording measurements from body composition analyzers and blood pressure monitors in a personal health record (PHR) may contribute to improvements in body weight and blood pressure.
    JPX · 2026/9/18
  • D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $13
    \u5e02\u573a\u8d44\u8baf · 2026/9/4
  • 评级变动
    Truist Financial Maintains Phreesia(PHR.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/3
  • 公司公告
    Techmatrix: PSP: Yokohama Municipal Minato Red Cross Hospital has adopted the PHR app "NOBORI."
    JPX · 2026/6/1
  • 评级变动
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Phreesia医疗支付 讨论区 0 条评论

发表评论